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Background
Heterogeneity of cancer poses a huge challenge for select-
ing effective treatment. Gene expression data has helped
identify different subtypes also of breast cancer [1] which
has led to improved patient stratification and therapeutic
strategies. However, treatment of the triple negative
(TNBC) subtype, which develops independent of hormone
and other receptors, still remains challenging also due to
heterogeneity within this subtype [2]. Metabolic transfor-
mation in cancer has long been discovered but only
recently has this phenomenon gained attention in cancer
research. Using the METABRIC dataset [1] of 2000
patients we identified key metabolic pathways that are
deregulated in breast cancer and further subdivided these
changes into the breast cancer subtypes. Combining
bioinformatic modeling with experimental data we aimed
to understand the flow of metabolites through pathways
and identify potential therapeutic targets.
Materials and methods
Metabolic genes identified in the METABRIC dataset [1]
to be informative on survival were selected to classify
patients into good and bad prognosis. We constructed a
mathematical model containing reactions of the central
carbon and nitrogen metabolism to predict flux distribu-
tions in several breast cancer cell lines. For quantification
of metabolites in breast cancer cells grown in standard
medium we used HPLC.
Results
Genes in glutamine metabolism and urea cycle were
upregulated in patients with bad outcome in the
METABRIC dataset [1]. This upregulation was most
prominent in the TNBC subtype. Our model predicts
that TNBCs have an elevated uptake of glutamine and
decompose nitrogen as urea. Using HPLC we identified
that glutamine consumption was highest in MDA MB
468 cells and the urea cycle is strongly upregulated in
this basal subtype of TNBC.
Conclusion
We have established a mathematical model of metabolic
transformation in breast cancer that predicts the urea
cycle to be particularly deregulated in the TNBCs. Using
in vitro experiments we validated this model and observed
that even within TNBC there are metabolic differences. In
future we will perform perturbation experiments to inves-
tigate if our findings can be exploited for TNBC treatment.
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